Hepatic function testing
- 1 September 1978
- journal article
- research article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 64 (3) , 177-185
- https://doi.org/10.1080/00325481.1978.11714929
Abstract
The clinical situation determines the choice of hepatic function tests. Alkaline phosphatase (ALP) and aspartate aminotransferase (GOT) tests serve to detect disease, and when used in combination with a gammaglutamyl transferase (GGTP) test, to exclude it. The combination of ALP, GOT, bilirubin, lactate dehydrogenase (LDH), albumin, globulin, and GGTP tests is useful for routine differential diagnosis. Prothrombin time indicates severity of disease. Interpretation is facilitated by attention to ALP or GOT predominance; the relationship of LDH, ALP, and bilirubin; and the ratio of GGTP to ALP. Abnormalities on routine tests frequently do no more than point out the need for more definitive procedures.Keywords
This publication has 9 references indexed in Scilit:
- Chronic hepatitis.BMJ, 1977
- Detection of hepatic metastases from cancer of the breastThe American Journal of Surgery, 1977
- DOES GILBERT'S DISEASE EXIST?The Lancet, 1977
- PREDICTING PROGRESSION OF ACUTE TYPE-B HEPATITIS TO CHRONICITYThe Lancet, 1976
- Liver FunctionHuman Pathology, 1975
- Role of Serial Plasma C.E.A. Assays in Detection of Recurrent and Metastatic Colorectal CarcinomasBMJ, 1974
- Carcinoembryonic antigen (CEA) assayA laboratory adjunct in the diagnosis and management of cancerHuman Pathology, 1974
- The Presentation and Diagnosis of 100 Patients with Primary Biliary CirrhosisNew England Journal of Medicine, 1973
- A Critical Look at the Value of Biochemical Liver Function Tests with Special Reference to Discriminant Function AnalysisAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1970